Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Net Cash Flow (2016 - 2025)

Palisade Bio (PALI) has disclosed Net Cash Flow for 16 consecutive years, with -$190000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Net Cash Flow rose 94.27% to -$190000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.8 million, a 61.32% increase, with the full-year FY2024 number at -$2.6 million, down 5428.57% from a year prior.
  • Net Cash Flow was -$190000.0 for Q3 2025 at Palisade Bio, up from -$1.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $9.0 million in Q3 2022 to a low of -$3.9 million in Q1 2022.
  • A 5-year average of -$335125.0 and a median of -$1.1 million in 2023 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: crashed 3829.59% in 2022, then soared 286.9% in 2023.
  • Palisade Bio's Net Cash Flow stood at -$98000.0 in 2021, then crashed by 1534.69% to -$1.6 million in 2022, then crashed by 79.78% to -$2.9 million in 2023, then surged by 161.84% to $1.8 million in 2024, then tumbled by 110.67% to -$190000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Net Cash Flow are -$190000.0 (Q3 2025), -$1.8 million (Q2 2025), and -$2.6 million (Q1 2025).